ImportantCommencement of commercial production/operations

CORONA Remedies commences commercial production at its EU-GMP approved Women's Hormone facility in Bhayla, Ahmedabad.

CORONA Remedies LimitedCORONA · Filed with the exchange

The facility has a capacity of 194 million tablets/capsules and 1.5 million ointments/gels annually, boosting in-house hormone production by ~20%.

Read the original filing(PDF)

No comments yet. Be the first.

More from CORONA Remedies Limited

All announcements